Azitra, Inc.(AZTR)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.7M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
AZTR Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Azitra, Inc. (AZTR), a Healthcare sector company. AZTR is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.7m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Azitra, Inc. reports net income of $-3.3M, free cash flow of $-3.3M. Top institutional holders of AZTR by reported 13-F value include Stonepine Capital Management, Dauntless Investment Group, Nantahala Capital Management, based on the most recent SEC filings. AZTR trades on the NYSE exchange and files with the SEC under CIK 1701478. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AZTR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Azitra, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-3.3M
Free Cash Flow
Q2 2026
$-3.3M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-100.0% YoYNet Income
-22.2% YoYOperating Income
+0.2% YoYEPS (Diluted)
+85.7% YoYTotal Assets
-31.7% YoYOp. Cash Flow
-10.2% YoYFree Cash Flow
-10.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $0.00 -100.0% | $7.5K -98.9% | $686.0K +141.5% | $284.0K | — |
| Net Income | $-11.0M -22.2% | $-9.0M +20.5% | $-11.3M -5.6% | $-10.7M | — |
| Operating Income | $-11.0M +0.2% | $-11.0M -47.4% | $-7.5M +21.2% | $-9.5M | — |
| EPS (Diluted) | $-2.25 +85.7% | $-15.70 +71.4% | $-54.98 -331.6% | $-12.74 | — |
| Total Assets | $5.0M -31.7% | $7.4M +43.9% | $5.1M -28.6% | $7.2M | — |
| Operating Cash Flow | $-11.2M -10.2% | $-10.2M -38.3% | $-7.4M +11.8% | $-8.3M | — |
| Free Cash Flow | $-11.2M -10.4% | $-10.2M -37.9% | $-7.4M +11.9% | $-8.4M | — |
Get alerted when AZTR's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Azitra, Inc. including:
Top Institutional Holders of AZTR
Stonepine Capital Management, LLC
$8.0M81,797,553 shDauntless Investment Group, LLC
$1.9M11,292,186 shNantahala Capital Management, LLC
$371.4K2,213,613 shJANE STREET GROUP, LLC
$41.7K248,433 shGEODE CAPITAL MANAGEMENT, LLC
$16.0K95,409 shCITADEL ADVISORS LLC
$14.5K86,242 shVirtu Financial LLC
$11.0K64,940 shUBS Group AG
$8.5K50,481 shStoneX Group Inc.
$5.0K28,651 shTower Research Capital LLC (TRC)
$3.3K19,500 sh
| Fund | Value | Shares |
|---|---|---|
| Stonepine Capital Management, LLC | $8.0M | 81,797,553 |
| Dauntless Investment Group, LLC | $1.9M | 11,292,186 |
| Nantahala Capital Management, LLC | $371.4K | 2,213,613 |
| JANE STREET GROUP, LLC | $41.7K | 248,433 |
| GEODE CAPITAL MANAGEMENT, LLC | $16.0K | 95,409 |
| CITADEL ADVISORS LLC | $14.5K | 86,242 |
| Virtu Financial LLC | $11.0K | 64,940 |
| UBS Group AG | $8.5K | 50,481 |
| StoneX Group Inc. | $5.0K | 28,651 |
| Tower Research Capital LLC (TRC) | $3.3K | 19,500 |
More Healthcare Companies
View all Healthcare →Put AZTR on your watchlist
Track score changes the day Azitra, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is AZTR a good stock to buy?
13F Pro's AI-powered analysis of Azitra, Inc. (AZTR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AZTR are available on the AZTR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. AZTR is classified as a small company.
Which hedge funds own AZTR?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AZTR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Azitra, Inc.'s investment landscape.